null
SMILES: Cc1ccc(NC(=O)c2ccnc(c2)C(C)(F)F)cc1-c1cnc2[C@H](O)C[C@@H]3COCCN3c2c1
InChI Key: InChIKey=WLZSAQBJFKJRMS-DENIHFKCSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RAF proto-oncogene serine/threonine-protein kinase [Y340E,Y341E] (Homo sapiens (Human)) | BDBM410348 (US10377770, Example 108) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 0.0130 | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis AG US Patent | Assay Description The activity of a compound according to the present invention can be assessed by well-known in vitro & in vivo methods. Raf inhibition data provided ... | US Patent US10377770 (2019) BindingDB Entry DOI: 10.7270/Q25X2C9T | |||||||||||
More data for this Ligand-Target Pair |